Systemic lupus erythematosus (SLE) is a chronic, inflammatory, autoimmune disease. This means that the body’s immune system is “imbalanced” leading to the production of autoantibodies directed against healthy tissues in the body in addition to producing antibodies for protection against infections.
Over time, the disease can potentially affect many different organs and tissues in the body. Lupus significantly affects women more often than men, in a ratio of 9:1. It mainly manifests in women between the ages of 15 and 44 but in recent years it has also been observed in children and older adults.
The clinical manifestations of the disease vary greatly among different patients and over the course of the disease. Some of the most common symptoms of lupus include painful and swollen joints (arthritis), excessive fatigue, skin rashes, anaemia, and kidney problems.
The treatment of lupus is complex and often requires the efforts of a multidisciplinary team of specialists – rheumatologists, clinical immunologists, nephrologists, cardiologists, haematologists, dermatologists, neurologists, endocrinologists, and others.